6. Characteristics of studies with WHO X‐ray defined pneumonia.
Study | Age at enrolment | Follow up | Age at completion of primary series | Setting | No. of participants | PCV serotypes |
Hansen 2006 | 2 months | Earliest of the following dates: onset of first invasive disease, death, end of trial | 12 months | Northern California Kaiser Permanente (NCKP) | 37,868 | 4, 6B, 9V, 14, 18C, 19F, 23F |
Cutts 2005 | 6‐51 weeks | Earliest of the following dates: first episode of the relevant endpoint, withdrawal, death, age 30 months, end of follow‐up on April 30, 2004 | 6 months | The Gambia | 17,437 | 1, 4, 5, 6B, 9V, 14, 18C, 19F, 23F |
Klugman 2003 (HIV‐1 negative children only) |
28‐84 days | 60‐1354 days after enrolment | 9 months | Soweto, South Africa | 37,259 | 1, 4, 5, 6B, 9V, 14, 18C, 19F, 23F |
Lucero 2009 | 6 weeks‐ < 6 months | Earliest of the following dates: 24 months of age, end of follow‐up on December 31, 2004 | 6 months | Philippines | 12,191 | 1, 3, 4, 5, 6B, 7F, 9V, 14, 18C, 19F, 23F |
O'Brien 2002 | 6 weeks‐7 months of age | First 24 months of life | 12 months | American Indian and Apache Indian Reservations | 5792 | 4, 6B, 9V, 14, 18C, 19F, 23F |